Quest PharmaTech (CVE:QPT) Sets New 52-Week Low at $0.02

Shares of Quest PharmaTech Inc. (CVE:QPTGet Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 12620 shares changing hands. The stock had previously closed at C$0.03.

Quest PharmaTech Trading Down 20.0 %

The firm has a market capitalization of C$3.38 million, a PE ratio of -0.17 and a beta of 0.25. The company has a quick ratio of 0.52, a current ratio of 0.26 and a debt-to-equity ratio of 1.51. The stock’s fifty day simple moving average is C$0.03 and its 200 day simple moving average is C$0.04.

Quest PharmaTech Company Profile

(Get Free Report)

Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.

Featured Stories

Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.